Free Trial

Deutsche Bank AG Grows Stock Position in UiPath, Inc. $PATH

UiPath logo with Computer and Technology background

Key Points

  • Deutsche Bank AG increased its position in UiPath, Inc. by 3.8% to a total of $16.09 million, owning 1,562,306 shares as of its latest SEC filing.
  • Several hedge funds have recently adjusted their stakes in UiPath, with a significant increase from Maxi Investments CY Ltd by 90.1% in the first quarter.
  • UiPath's shares saw a 2.3% increase in mid-day trading, reaching $10.98, following the company’s earnings report that beat analysts' expectations.
  • Want stock alerts on UiPath? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Deutsche Bank AG increased its stake in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 3.8% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,562,306 shares of the company's stock after buying an additional 56,721 shares during the period. Deutsche Bank AG owned about 0.28% of UiPath worth $16,092,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Versant Capital Management Inc increased its stake in shares of UiPath by 198.6% in the first quarter. Versant Capital Management Inc now owns 2,962 shares of the company's stock worth $31,000 after purchasing an additional 1,970 shares in the last quarter. CX Institutional bought a new stake in UiPath during the first quarter valued at approximately $36,000. True Wealth Design LLC lifted its position in UiPath by 18.4% during the fourth quarter. True Wealth Design LLC now owns 5,163 shares of the company's stock valued at $66,000 after purchasing an additional 801 shares during the last quarter. MRP Capital Investments LLC bought a new stake in UiPath during the first quarter valued at approximately $82,000. Finally, Meeder Advisory Services Inc. bought a new stake in UiPath during the first quarter valued at approximately $105,000. Hedge funds and other institutional investors own 62.50% of the company's stock.

Insider Activity

In other UiPath news, CFO Ashim Gupta sold 56,322 shares of the company's stock in a transaction dated Wednesday, July 2nd. The shares were sold at an average price of $12.72, for a total transaction of $716,415.84. Following the transaction, the chief financial officer owned 859,991 shares in the company, valued at approximately $10,939,085.52. This represents a 6.15% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Daniel Dines sold 45,000 shares of the company's stock in a transaction dated Wednesday, July 16th. The shares were sold at an average price of $12.43, for a total transaction of $559,350.00. Following the transaction, the chief executive officer owned 5,058,376 shares in the company, valued at $62,875,613.68. This represents a 0.88% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 831,310 shares of company stock worth $10,428,922 in the last 90 days. Company insiders own 23.19% of the company's stock.

Wall Street Analysts Forecast Growth

PATH has been the subject of several research analyst reports. Barclays reiterated an "equal weight" rating on shares of UiPath in a research report on Friday, May 30th. Royal Bank Of Canada lifted their target price on shares of UiPath from $13.00 to $15.00 and gave the stock a "sector perform" rating in a research note on Friday, May 30th. Zacks Research raised shares of UiPath to a "hold" rating in a research note on Friday, August 8th. Wells Fargo & Company reaffirmed an "equal weight" rating on shares of UiPath in a research note on Friday, May 30th. Finally, BMO Capital Markets lifted their target price on shares of UiPath from $11.50 to $15.50 and gave the stock a "market perform" rating in a research note on Friday, May 30th. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, UiPath currently has an average rating of "Hold" and a consensus target price of $13.83.

Get Our Latest Stock Report on PATH

UiPath Stock Performance

Shares of UiPath stock traded up $0.20 during trading on Monday, hitting $11.16. The company's stock had a trading volume of 5,869,159 shares, compared to its average volume of 11,685,489. The company has a fifty day simple moving average of $12.22 and a two-hundred day simple moving average of $12.16. The company has a market capitalization of $5.97 billion, a PE ratio of -92.87, a P/E/G ratio of 14.36 and a beta of 1.03. UiPath, Inc. has a 52 week low of $9.38 and a 52 week high of $15.93.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The company had revenue of $356.62 million during the quarter, compared to analyst estimates of $332.17 million. During the same period last year, the business earned $0.13 EPS. UiPath's quarterly revenue was up 6.4% compared to the same quarter last year. As a group, analysts predict that UiPath, Inc. will post -0.17 EPS for the current year.

UiPath Company Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Articles

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines